Outset Medical More Than Doubles Sales In FY21, Issues Better Than Expected FY22 Outlook
Outset Medical Inc (NASDAQ:OM) recorded Q4 FY21 net revenue of $28.2 million, a 63.2%, beating the consensus of $26.42 million. Product revenue for the fourth quarter of 2021 was $23.7 million, +79.5%. The Company achieved a gross margin of 11.8%, compared to 2.4% in the fourth quarter of 2020 Select Development: The…
Benzinga ·